500 patients67,039 observations150 daysLIVE
← Patients

Patient P-03373

Synthetic patientONX-7 · Day 142 · 35–44 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
9%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 started — Baseline state S17
  2. Day 90 BR-03 recommended — Behavioural Recommendation BR-03
  3. Day 91 Patient accepted — Started BR-03 in the companion
  4. Day 98 GI symptom burden −14% vs expected — Behavioural Recommendation BR-03
  5. Day 104 Tolerance state changed — Unstable → Improving
  6. Day 106 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 106.

Primary contributors, last 14 days
  • Nutritional resilience+11
  • Treatment adherence+11
  • GI instability-3

What helped?

  • Behavioural Recommendation BR-03Day 90
    Result: symptom burden −14%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
6.5/10
improving · +0.7 vs previous 14 d
Stress level
Daily log
3.4/10
improving · -0.3 vs previous 14 d
Pessimism score
Daily log
4.6/10
stable · -0.1 vs previous 14 d
Sleep quality
Wearable
47.6/100
improving · +4.9 vs previous 14 d
Libido
Daily log
4.9/10
stable · +0.1 vs previous 14 d
HRV
Wearable
56.1 ms
stable · +1.1 vs previous 14 d
Toxicity
Blood
17.8/100
worsening · +6.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 75 from the failing basin, 45 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -4.4 next day on high-intake days · n 18
Would not help
  • AD-05 Adherence Support
    only 29% improved among 14 similar
  • Keep histamine low
    GI +4 next day on high-intake days · n 24
  • Keep lactose low
    GI +3.1 next day on high-intake days · n 16
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -4.4supporter · 95%
  • Histamine load
    +4detractor · 95%
  • Lactose
    +3.1detractor · 79%
  • Alcohol
    -1no signal · 27%
  • Caffeine
    -0.7no signal · 18%
  • Dietary fat load
    -0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity ↓30
    • DNAFUT2 non-secretor lowers mucosal fucosylation
  • Inflammatory signalling ↓20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Intermediate metabolizer
    Expected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 69/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
55 ms
Sleep
6.4 h
Steps
3,424
Resting HR
70 bpm
Daily log: GI score 11, nutritional resilience 76, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0338046%S16AD-05improved34
P-0342640%S18BR-03improved27
P-0323539%S13GI-04improved29
P-0327738%S14BR-03improved41
P-0344138%S19AD-05improved37
P-0320437%S16AD-05improved48
P-0342437%S12AD-05improved41
P-0301336%S07GI-04improved30
P-0311435%S11DT-01improved48
P-0314335%S11DT-01improved49
P-0323335%S19DT-01improved47
P-0330735%S03ME-01improved17